Trial intelligence / Profile preview

Vitamin C vs i-PRF for Thin Gingival Phenotype

NCT05841303Phase 4Unknown

Sponsor
Cairo University
Start
Jul 2023
Primary completion
Mar 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of ascorbic acid (2 arms), sponsored by Cairo University. Primary endpoint: Gingival Thickness at 6 months. Status: unknown.

02

Drugs

ascorbic acid

Beyond the preview

Go deeper on NCT05841303.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05841303.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call